
AIBODY provides digital physiology software for healthcare and medical education. Their core technology is based on a bottom-up approach to modeling digital physiology, encompassing 132,000 parameters from subcellular to organism-level functions and pharmacokinetics. This enables the simulation of biochemical and biomechanical transformations, creating digital twins of human organs and systems. Their products include solutions for medical education and training, offering interactive simulations and AI-powered teaching assistants built with Large Language Models. They also develop clinical-grade digital twinning solutions for healthcare, such as Nova Heart, a digital twin of the heart created from echocardiograms. AIBODY's models undergo rigorous validation against empirical data and clinical studies.

AIBODY provides digital physiology software for healthcare and medical education. Their core technology is based on a bottom-up approach to modeling digital physiology, encompassing 132,000 parameters from subcellular to organism-level functions and pharmacokinetics. This enables the simulation of biochemical and biomechanical transformations, creating digital twins of human organs and systems. Their products include solutions for medical education and training, offering interactive simulations and AI-powered teaching assistants built with Large Language Models. They also develop clinical-grade digital twinning solutions for healthcare, such as Nova Heart, a digital twin of the heart created from echocardiograms. AIBODY's models undergo rigorous validation against empirical data and clinical studies.
What they do: High-resolution digital physiology platform (132,000-parameter digital human) for medical education and clinical simulation
Founded / HQ: April 2020; London, United Kingdom
Team size: ~24 employees
Funding signal: Recorded non-equity assistance (Jun 11, 2025) and an earlier round (Mar 18, 2021); investors include Raw Ventures and Google for Startups
Medical education, clinical simulation, device testing, pharmacokinetics
2020
Health / Medical Education / Digital Twins
Recorded as a non-equity assistance award
“Investors reported include Raw Ventures and Google for Startups”